The oxidative coupling of photogenerated alkyl radicals with readily available styrenes is disclosed. This visible-light-mediated method allows rapid access to a wide range of α-alkyl-acetophenones in good yields and with high functional group tolerance. In addition, the developed protocol features room temperature conditions, low photocatalyst loadings, and the use of dimethyl sulfoxide as nontoxic
Nickel‐Catalyzed Reductive Acylation of Carboxylic Acids with Alkyl Halides and
<i>N</i>
‐Hydroxyphthalimide Esters Enabled by Electrochemical Process
作者:Xiao Zhou、Lin Guo、Haoxiang Zhang、Raymond Yang Xia、Chao Yang、Wujiong Xia
DOI:10.1002/adsc.202200003
日期:2022.4.26
A sustainable Ni-catalyzed reductive acylation reaction of carboxylic acids via an electrochemical pathway is presented, affording a variety of ketones as major products. The reaction proceeds at ambient temperature using unactivated alkyl halides and N-hydroxyphthalimide (NHP) esters as coupling partners, which exhibits several synthetic advantages, including mild conditions and convenience of amplification
SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES
申请人:Masarykova univerzita
公开号:EP3556755A1
公开(公告)日:2019-10-23
The invention provides compounds represented by the structural formula (1):
wherein R1, R2, R3, R4, R5, R6 are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.
[EN] PREPARATION METHOD FOR TRICYCLIC COMPOUND AND USE OF SAME IN FIELD OF MEDICINE<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSÉ TRICYCLIQUE ET SON UTILISATION DANS LE DOMAINE DE LA MÉDECINE<br/>[ZH] 三环类化合物制备方法及其在医药领域的应用
申请人:SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD
[EN] SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES<br/>[FR] AMINOTHIAZOLES SUBSTITUÉS UTILISÉS EN TANT QU'INHIBITEURS DE NUCLÉASES
申请人:UNIV MASARYKOVA
公开号:WO2019201865A1
公开(公告)日:2019-10-24
The invention provides compounds represented by the structural formula (1): wherein R1, R2, R3, R4, R5, R6 are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.